For over three decades, CEI has advocated health care reforms that put more power in the hands of consumers to choose their health providers, treatment protocols, and scope of insurance coverage. We have advocated reform of the Food and Drug Administration’s drug and device approval process to allow for greater flexibility and patient choice. And in 2013, CEI organized the court challenges to Obamacare’s exchange subsidies that concluded with the Supreme Court’s King v. Burwell decision.
Healthcare Issue Areas
Featured Posts

Blog
The current state of pharmaceutical tariffs
Background Amid the Trump trade upheaval, pharmaceutical products receive different treatment than many other US imports. Pharmaceuticals are treated differently for reasons such as their…

DC Journal
Point: Medicaid Work Requirements Are a Common-Sense Reform
Medicaid is the government program that is supposed to help the poor afford health care. Its cost to taxpayers has skyrocketed in the last few…

Blog
Congress considers micromanaging PBM finances
With the first reconciliation bill behind it, Congress is now looking to reform other aspects of the health care system. Pharmacy Benefit Manager (PBM)…
Search Posts
CNS News
COVID-19 May Be Bad News for Environmentalist Bullies
The economic destruction wrought by the coronavirus pandemic has been severe and global. More than 10 million Americans lost their jobs and applied for unemployment benefits in…
Blog
VIDEO: Road Map to Reopening
The U.S. Chamber of Commerce hosted a fascinating video conference this week entitled “Big Picture: Road Map to Reopening,” with the Chamber’s Suzanne Clark and…
Blog
Apple and Google Demonstrate Big Tech Done Right Can Make Big Government Obsolete
Many see the purpose of government as solving problems that otherwise wouldn’t be efficiently addressed in its absence. Yet, despite the steady growth of government,…
Blog
Medical Supply Sterilization Plant Employee Corrects Chicago Tribune’s Misleading Coverage
An April 13 letter to the editor in the Chicago Tribune addresses the paper’s misleading and alarmist narrative about the use of ethylene oxide (EtO).
Blog
How to Spot a #NeverNeeded Regulation
Not every regulation on the books is directly harming the COVID-19 response. There are a lot of other regulations that need reform, but the #NeverNeeded…
Inside Sources
Post-Virus Economics – Working Toward a Small Business Recovery
When the stay-at-home orders are lifted, we’ll be in a race to get millions of Americans back to work. Large companies will be in a…